<DOC>
	<DOCNO>NCT01346488</DOCNO>
	<brief_summary>This single-arm , multi-center , prospective cohort study ( post-marketing observational study ) . The observation period participant 48 week . This study design provide additional data treatment effect adalimumab 48 week treatment patient RA condition routine rheumatology care . Course work productivity work ability , course health-related quality life , change functionality 48 week treatment adalimumab document .</brief_summary>
	<brief_title>Special Investigation Patients With Rheumatoid Arthritis ( Working Productivity Activity Impairment )</brief_title>
	<detailed_description>This study design non-interventional observational study . Adalimumab prescribe usual manner accordance term local market authorization regard dose , population indication well local guideline .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>RA patient treat adalimumab satisfied follow condition : 1 . Paid worker ( PW ) RA patient engage pay work 35 hour per week 2 . Home worker ( HW ) Category 1 unpaid worker ; RA patient engage pay work le 35 hour per week Category 2 unpaid worker ; RA patient perform basic activity daily life ( household duty , shopping , child caring , exercise , study , etc . ) PW 1 . RA patient show lowered basic activity daily life , hospitalization bedridden 2 . RA patient history previous treatment adalimumab</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>87 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>